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Abstract
A recent experimental study investigating patients with lone atrial fibrillation identified six
novel mutations in the KCNA5 gene. The mutants exhibited both gain- and loss-of-function
of the atrial specific ultra-rapid delayed rectifier K+ current, IKur. The aim of this study is to
elucidate and quantify the functional impact of these KCNA5 mutations on atrial electrical
activity. A multi-scale model of the human atria was updated to incorporate detailed experi-
mental data on IKur from both wild-type and mutants. The effects of the mutations on human
atrial action potential and rate dependence were investigated at the cellular level. In tissue,
we assessed the effects of the mutations on the vulnerability to unidirectional conduction
patterns and dynamics of re-entrant excitation waves. Gain-of-function mutations shortened
the action potential duration in single cells, and stabilised and accelerated re-entrant excita-
tion in tissue. Loss-of-function mutations had heterogeneous effects on action potential
duration and promoted early-after-depolarisations following beta-adrenergic stimulation. In
the tissue model, loss-of-function mutations facilitated breakdown of excitation waves at
more physiological excitation rates than the wild-type, and the generation of early-after-
depolarisations promoted unidirectional patterns of excitation. Gain- and loss-of-function
IKur mutations produced multiple mechanisms of atrial arrhythmogenesis, with significant dif-
ferences between the two groups of mutations. This study provides new insights into under-
standing the mechanisms by which mutant IKur contributes to atrial arrhythmias. In addition,
as IKur is an atrial-specific channel and a number of IKur-selective blockers have been devel-
oped as anti-AF agents, this study also helps to understand some contradictory results on
both pro- and anti-arrhythmic effects of blocking IKur.
Author summary
In a recent study, six mutations resulting in either gain-of-function or loss-of-function in
the ultra-rapid delayed rectifier potassium current IKur, were identified to be associated
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with atrial fibrillation (AF). However, the causative link between the mutant IKur (either
gain- or loss-of-function) and AF genesis, especially the difference and similarity between
the two mutant groups, has not been elucidated. In our study, we used multiscale compu-
tational models to investigate the mechanism of arrhythmogenesis mediated by the two
groups of mutations. The results suggest that the gain-of-function mutations shortened
atrial action potential duration, stabilised and accelerated re-entrant excitation waves in
tissue; the loss-of-function mutation promoted early-after-depolarisations following beta-
adrenergic stimulation and thus wave breaks in tissue. We show these two groups of
mutants carrying IKur produced multiple mechanisms of atrial arrhythmogenesis, with
significant differences between the two groups. Our study provides new insights into
understanding the mechanisms by which mutant IKur contributes to atrial arrhythmias. In
addition, as IKur is an atrial-specific channel and a number of IKur-selective blockers have
been developed as anti-AF agents, this study also helps to understand some contradictory
results on both pro- and anti-arrhythmic effects of blocking IKur.
Introduction
Mutations in genes encoding the proteins involved in cardiac electrophysiology can result in
alterations of the electrical action potential (AP) and tissue excitability, which may affect car-
diac output and predispose to arrhythmias, such as atrial fibrillation (AF) [1,2].
AF, the world’s most common cardiac arrhythmia [3], is characterised by complex and
rapid electrical activation of the upper chambers of the heart, impairing cardiac function and
significantly increasing the risk of heart failure, stroke and death [4]. Electrical activity driving
AF is conjectured to be underlain by ectopic pacing (abnormal spontaneous activity), re-
entrant excitation (in the form of scroll waves or wavelets), or an interplay between both [5,6].
AF can arise within the context of other heart conditions, such as heart failure, and is in
general associated with large-scale and multi-faceted electrical and structural remodelling [7–
9], but may also occur in the presence of individual genetic mutations in the otherwise normal
heart (referred to as ‘lone’ or ‘familial’ AF). Understanding the pro-arrhythmic role of genetic
variation is an essential part of the wider effort to understand and treat the cardiac disorder.
The ultra-rapid potassium current (IKur) plays an important role in repolarisation of the
atrial action potential in human and other animals [2,10]. Alterations to the biophysical prop-
erties of IKur are associated with incidences of AF [2,8]. A recent study analysing patients with
lone AF has identified six mutations in the human KCNA5 gene, which encodes the Kv1.5
channel carrying IKur [2]. Of the six mutations, three resulted in a gain-of-function (D322H,
A305T, E48G) and three in a loss-of-function (P488S, Y155C, D469E) of the current. All muta-
tions resulted in alterations of the channel’s maximum current density and kinetics [2], which
is likely to manifest as modifications to AP morphology and duration.
AP morphology and duration are critical factors determining complex electrical wave
dynamics in tissue, such as those observed during AF. Previous studies have demonstrated
that AP duration (APD) abbreviation plays an important role in sustaining re-entrant circuits
[11–13]. Moreover, large gradients in AP morphology and duration across different regions of
the atria can promote wave-breaks, leading to unidirectional conduction patterns that can
develop into self-perpetuating re-entrant excitation [13–15]. IKur is active during the plateau
and early repolarisation phase of the human atrial AP, affecting AP morphology and duration
and thus providing the potential to perpetuate and facilitate atrial arrhythmias.
Pro-arrhythmic effects of KCNA5 gene mutations
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Recent experimental and modelling studies have also demonstrated an important role for
IKur in the incidence of early-after-depolarisations (EADs) during beta-adrenergic stimulation
(sympathetic nervous response) in isolated cells [16,17]. After-depolarisations are generally
linked with arrhythmogenic mechanisms [18–20] and thus mutations which affect IKur
dynamics may also mediate arrhythmogenesis through the promotion of EADs.
Diversity in IKur kinetics associated with genetic variation of KCNA5 therefore presents the
possibility to facilitate atrial arrhythmogenesis through different mechanisms. Determining
these mechanisms is the aim of the present study. This is achieved through integrating experi-
mental data on diversity in IKur kinetics into a multi-scale computational model of the human
atria, used to elucidate the functional impact of the six identified mutations on electrical activ-
ity at the cellular and tissue scale. In order to exclude possible model-dependent results and
conclusion, three contemporary mathematical models of human atrial electrophysiology
[13,17,21] were implemented in this study.
Results
Gain-of-function mutations
All gain-of-function mutations had a marked effect on AP morphology and duration (Fig 1A,
detailed description in S1 Text). In lone AF, the notch and plateau potentials and APD30 were
reduced, and APD90 was in general shortened; the APD restitution curves were flattened. With
the inclusion of chronic AF (cAF) electrical remodelling, all mutations shortened the APD90 in
all models (S2 Text).
In simulations using the Colman et al. [13] and Courtemanche et al. [21] single cell models
mapped onto the 3D reconstruction of human atrial anatomy, all three gain-of-function muta-
tions promoted stable, higher frequency re-entrant scroll waves compared to the WT in all
models (Fig 1B, Figure A in S3 Text). Re-entry could also be sustained at larger values of the
diffusion coefficient (D), closer to control, indicating an increased susceptibility to re-entry in
the structurally normal atria, or atria with a normal electrical coupling (Table A in S3 Text).
cAF remodelling accelerated and thus stabilised re-entrant excitation in all mutations and WT
compared to the lone AF condition and in all mutations compared to the WT (Fig 1Bi,ii).
The extent of APD90 variation across electrically heterogeneous regions was in general
reduced by these mutations compared to the WT; APD90 variation was also reduced in cou-
pled tissue compared to single cells for all conditions (Fig 1Ci,ii). However, at the heteroge-
neous junction of crista terminalis/pectinate muscle (CT/PM), the in-tissue APD90 difference
between the two regions was only affected by a small degree by the mutations. Correspond-
ingly, the mutations had only a small effect on the width of the vulnerability windows (VWs)
under S1S2 pacing, but caused a marked shift to the excitation cycle-lengths of S2 over which
the VWs were observed (Fig 1Ciii, S4 Text).
Loss-of-function mutations
Loss-of-function mutations markedly altered AP morphology, but had a less marked and con-
sistent effect on APD90 among the three models: enhanced plateau/dome phase of the AP and
thus APD30 was observed in all mutations, but secondary effects on terminal repolarisation led
to variations in modulation of APD90 (Fig 2A and discussed further in S1 Text); in different
models and mutations, the effects on APD90 ranged from substantial prolongation to slight
shortening (Fig 2A). Note that in previous experimental studies, blocking IKur either resulted
in an increase [7] or decrease [22] in APD of human atrial cells depending on the baseline
morphology of the atrial AP.
Pro-arrhythmic effects of KCNA5 gene mutations
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Under cAF conditions, consistent effects were observed between the individual mutations
in the three models (S2 Text): all mutations elevated AP-plateau and prolonged APD90.
In 3D organ-scale simulations, the mutations presented inconsistent effects on the stability
of re-entrant excitation: D469E and Y155C had very little effect on the dominant frequency in
Fig 1. Effects of gain-of-function KCNA5 mutations. A Effects of the mutations on the AP (i-iii) and APD-restitution (iv-vi) properties of human
atrial myocytes elicited by updated Colman et al. model, Courtemanche et al. model and Grandi et al. model. B Effects of the mutations on the
maximum sustained dominant frequency of excitation waves under the lone AF and chronic AF conditions using (i) Colman et al. model and (ii)
Courtemanche et al. model. C Effects of the mutations on APD heterogeneity and tissue vulnerability window at the CT/PM junction in Colman et al.
model. APD distribution among regional cells of whole atria and CT/PM for in (i) isolated single cells and (ii) in coupled tissue; the APD distribution in
tissue is shown in boxplots with outlier limits of 1.5×IQR (interquartile range). (iii) Temporal vulnerability window to propagation wave break at the CT/
PM junction.
https://doi.org/10.1371/journal.pcbi.1005587.g001
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the Colman et al. model (Fig 2Bi), whereas re-entry could not be sustained in P488S (transient
re-entry had a lifetime of less than a second, even in the severe remodelling condition), but in
the Courtemanche et al. model, the presence of alternans with D469E and Y155C destabilised
the re-entrant waves, leading to termination of rotors (Fig 2Bii, Figure B in S3 Text).
Fig 2. Effects of loss-of-function mutations. A Effects of the mutations on AP (i-iii) and APD-restitution (iv-vi) properties of human atrial
myocytes elicited by updated Colman et al. model, Courtemanche et al. model and Grandi et al. model. B Effects of the mutations on the maximum
sustained dominant frequency of excitation waves in the lone AF and chronic AF conditions using (i) Colman et al. model and (ii) Courtemanche
et al. model. C Effects of KCNA5 mutations on APD heterogeneity and tissue vulnerability window at the CT/PM junction in Colman et al. model.
APD distribution among regional cells of whole atria and CT/PM for in (i) isolated single cells and (ii) in coupled tissue; the APD distribution in tissue
is shown in boxplots with outlier limits of 1.5×IQR (interquartile range). (iii) Temporal vulnerability window to wave propagation break at the CT/PM
junction. In panel B, * indicates cases in which re-entrant waves could not be sustained.
https://doi.org/10.1371/journal.pcbi.1005587.g002
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Analogously to gain-of-function mutations, loss-of-function mutations increased APD90
heterogeneity across the atria, but had a relatively small effect on the heterogeneity at the CT/
PM junction and correspondingly the size of the VWs, whereas the shift in temporal window
of S2 over which wave breaks were observed (shifted to longer values) was more substantial
(Fig 2C, S4 Text).
Beta-adrenergic stimulation
The application of Isoprenaline (ISO, 1μM), replicating beta-adrenergic stimulation, had no
arrhythmogenic impact on myocytes with gain-of-function mutations or WT IKur (Figure A in
S5 Text). However, for the loss-of-function mutants pronounced EADs were observed in simu-
lations using the Grandi et al. model (Fig 3A, Figure B in S5 Text). In simulations across regional
cell models, the CT was more susceptible to the development of EADs than the PM and RA (Fig
3A) due to its larger expression of ICaL [13,14]: more substantial EADs were observed in the CT
for Y155C and P488S, whereas D469E led to EADs in the CT but none in the PM or RA.
Implications of observed EADs on tissue excitation patterns were evaluated in a 1D strand
of human atrial cell models. In these simulations, substantial EADs were observed (Fig 3B).
The increased susceptibility of the CT to EADs compared to the surrounding atria (PM, RA)
was also observed. Using a 1D strand model of the CT and PMs only, EADs in the CT (for the
case of D469E) could not cause a premature propagating excitation wave (i.e., focal activity)
into the adjacent PMs or RA (which did not exhibit EADs) under either rapid or slow S1
pacing.
An S1S2 pacing protocol was used to evaluate the effect of EAD-mediated APD prolonga-
tion on the VW at the heterogeneous CT/PM junction. For D469E plus ISO, a VW with a
substantial width (313 ms) and an upper limit at a long cycle length (689 ms) (Fig 3B) was
observed–significantly larger than WT or VWs computed in the absence of EADs. VWs of a
similar size were observed in all cases of heterogeneous EAD production resulting from a het-
erogeneous application of ISO (D469E at the CT/PM junction; non-uniform ISO distributions
for loss-of-function mutations).
1D tissue simulations including a spontaneously active sinoatrial node (SAN) with various
regional and ISO configurations (Fig 3C) indicated that production of EADs in the CT could
interrupt conduction patterns of excitation emanating from the SAN (Fig 3C): significant
EADs at both exit pathways from the SAN to the CT caused “skipped beats” through bi-direc-
tional block; EADs in only one pathway (non-uniform ISO distribution; short pathway to the
PM) resulted in unidirectional conduction block. Applied focal pacing was therefore not nec-
essary to induce potentially arrhythmic conduction patterns.
Discussion
In this study, the impact of six mutations in KCNA5 on human atrial electrical function was
investigated in silico, which elucidates and clarifies the arrhythmogenic effect of the six identi-
fied KCNA5 mutations, demonstrating a causal link between the mutations and incidence of
arrhythmia—a link which is distinctly different for the two groups of mutations. The opposing
effects on the AP due to gain- and loss- of-function mutations, and their respective mechanis-
tic pathways to induction of arrhythmia, indicate that pharmacological intervention to treat
the condition may need to be considered specifically for the genotype and the resulting pheno-
type. The presented results have implications that can be extrapolated beyond the specific
mutations, providing general insight into the role of IKur kinetics in atrial electrical function,
further to previous modelling [15,23–25] or experimental [26–28] studies, which primarily
have focused on anti-arrhythmic properties of IKur block/down-regulation alone.
Pro-arrhythmic effects of KCNA5 gene mutations
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Fig 3. KCNA5 loss-of-function mutations induced EADs following the beta-adrenergic stimulation. A(i) In the presence of ISO, EADs
were produced by Y155C and P488S, but not in WT or D469E in RA; (ii) EADs were induced by D469E in CT but not in PM. B Under uniform
application of ISO in a 1D strand model with D469E, EADs in the CT but not PM induced conduction block at an S2 of 689 ms (i) and success
at 690 ms (ii). C 1D conduction patterns under mutations and application of ISO in various configurations. On the left of each panel is a
breakdown of the regions in the 1D model and an illustration of the anatomical conduction pathway to which they correspond; on the right is
the regions of tissue to which ISO was applied. (i) Regular conduction pattern under WT and uniform ISO application; (ii) Under uniform
application of ISO, D469E led to alternating bidirectional conduction block due to EADs in the CT; (iii) D469E and non-uniform ISO can lead to
unidirectional conduction block, resulting from EADs in the CT regions with ISO; (iv) Unidirectional block can also be attained through a
different pathway to the PM, in which the CT on one side of the SAN is of insufficient extent to develop significant EADs. In the simulations
effects of beta-adrenergic stimulation was modelled by simulated application of ISO (1 μM).
https://doi.org/10.1371/journal.pcbi.1005587.g003
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Arrhythmia mechanisms of gain-of-function mutations
Gain-of-function mutations promoted the initiation and sustenance of arrhythmic re-entrant
excitation through shortening of the action potential duration and therefore excitation wave-
length [13].
In single cells, the increased activity of the repolarising current during phase-2 of the AP
led to a significant reduction of the plateau potential. In 8 out of 9 cases this directly contrib-
uted to shortened terminal repolarisation and refractory period and flattening of the APD
restitution curve, resulting in shorter refractory period across the range of pre-pacing cycle
lengths and thus promoting sustained re-entry [6]. The exception is D322H in the Colman
et al. model, which led to APD90 prolongation in single cells (Figure A in S1 Text). However,
even in this condition, with the additional load of electrotonic coupling (which compensates
for the loss of terminal repolarising currents IKs and IKr−discussed further in S3 Text), the in-
tissue APD was nonetheless shortened at the rapid rates associated with ectopic pacing and re-
entry (Figure A in S3 Text), leading to promotion of sustained re-entry.
Simulations in this study did not highlight a direct mechanism by which these mutations
promoted the initiation of re-entry (i.e. the VWs were not increased). However, other studies
have demonstrated that the presence of increased fibrotic lesions [29,30] can lead to conduc-
tion wave-breaks and the development of re-entry. In these conditions, it is well established
that a shortening of the wavelength enhances the probability of a wave-break developing into
self-perpetuating re-entry [5,13], and in the present study we have demonstrated that re-entry
is stabilised in these mutations once initiated, and that stable re-entrant waves could be sus-
tained in atria with less severe remodelling in the gap-junctions / structure (Table A in S3
Text). Therefore, AP shortening due to increased activity of IKur can promote both the initia-
tion and maintenance of re-entry, associated with AF, when combined with other factors
(such as ectopic pacing and fibrosis).
Arrhythmia mechanisms of loss-of-function mutations
Loss-of-function mutations enhanced the susceptibility of atrial tissue to the induction of
arrhythmia through a positive shift in the cycle lengths over which the VWs were observed
and enhanced vulnerability to EADs, but did not promote the sustenance of re-entrant excita-
tion. Enhanced vulnerability to the induction of wave-breaks may be mechanistically linked to
the development and subsequent breakdown of re-entry.
In single cell, the loss of repolarising current during phase 2 of the AP elevated the AP-pla-
teau. This could lead directly to a prolongation of the APD90, but through secondary effects on
other currents, the APD90 could be unchanged or slightly shortened compared to the WT (S1
Text). This inconsistency in the modulation of the refractory period led to variable effects on
the maintenance of re-entry.
This loss of repolarising current and elevation of the AP plateau also underlies enhanced
susceptibility to EADs when combined with ISO: the increased activity of ICaL is no longer
counteracted by sufficient repolarising IKur, leading to the possibility of re-activation of ICaL
driving an EAD (S5 Text). This mechanism has been previously observed in both experimental
and modelling studies in which IKur is pharmacologically blocked [16,17]. Whereas our simu-
lations did not demonstrate focal activity resulting from EADs (consistent with [19,31] which
demonstrated that phase 3 EADs, not phase 2 as observed in the present study, are necessary
for the development of focal activity), spatially heterogeneous production of EADs led to sig-
nificant in-tissue APD gradients and substantial VWs.
EADs in the CT were also observed to block excitation originating from the SAN, providing
a potential mechanism for the development of re-entry independent of ectopic pacing. Thus,
Pro-arrhythmic effects of KCNA5 gene mutations
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these mutations can promote the development of asymmetric conduction patterns which are a
precursor to re-entry, and promote both the initiation and recurrence of AF, when combined
with factors which promote sustained re-entry, such as connexin and structural remodelling
or further electrical remodelling. We note that these latter factors are likely necessary to fully
account for the incidence of AF in these patients.
The role of IKur in action potential morphology
Our results indicate a complex role for IKur kinetics and magnitude in atrial AP morphology,
which differed in variant models. Analysis demonstrated that the interplay between the extent
of activation of IKs and IKr and deactivation kinetics of IKur determined the dependence of
APD90 on IKur. Details are provided in S1 Text, but briefly: elevation or reduction of the AP
plateau led to enhanced or reduced activity in IKs and IKr, respectively. The impact of these sec-
ondary effects is determined by WT AP morphology, the extent of modulation directly by IKur,
the rapidity of IKur deactivation, and the formulations of IKs and IKr themselves, leading to dif-
ferent behaviour in different models and mutations. Due to inter-subject variations and inter-
cellular variations from the same patient, this non-linear behaviour may be clinically relevant.
Consistency between the models in cAF conditions results from the similar triangular AP mor-
phology exhibited by all models, wherein cAF remodelling dominates AF modulation.
Use of multiple, independent models of human atrial electrophysiology
Over the years, a number of mathematical models have been developed with different formula-
tions for ionic currents as well as intracellular calcium handling system based on different
experimental datasets [13,17,21,32]. Consequently these models produce variable electrophysio-
logical properties which represent the significant variations observed experimentally, including
three distinct AP profiles in human atrial myocytes [33]. In this study, three contemporary cell
models were implemented to ensure that simulation results and conclusions are model-inde-
pendent. Whereas the major conclusions were drawn from observations common to all models,
some specific behaviour did vary among the implemented models and warrants discussion.
Variation between the models and mutations regarding single cell is explained by the analy-
sis of the non-linear role of IKur in AP morphology (S1 Text). In this instance, use of multiple
models was essential in revealing this property and directly leads to our conclusions regarding
inconsistency in loss-of-function mutations modulating stable re-entry.
The genesis of EADs, and consequently the role in generating unidirectional conduction
block, was only observed in the Grandi et al. cell model. Whereas this behaviour could also be
induced in further simulations using the Nygren et al. model [34] (Figure C in S5 Text) it could
not be in the Courtemanche et al. and Colman et al. models (S5 Text). The authors note that
production of EADs due to ISO and a loss of IKur is experimentally observed [16] and natively
reproduced only by the Grandi et al. model, and it follows that such activity could result from
a loss-in-function mutation as well as a pharmacological blockade. Therefore it is likely that an
enhanced susceptibility to EADs due to loss-of-function mutations may be observed clinically
and warrants further investigation. Furthermore, our analysis of the effect of EADs on atrial
conduction patterns provides general mechanistic insight, beyond that specific to the muta-
tions studied, to the potentially arrhythmic role of EADs.
Clinical relevance
Whereas the present study provides insight into the link between the identified mutations in
KCNA5 and the incidence of AF, IKur is also of more general interest as a target for AF manage-
ment: it is atrial specific [2] and thus provides an attractive prospect for pharmacological
Pro-arrhythmic effects of KCNA5 gene mutations
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intervention because it can be targeted without adverse effects on the ventricles. Despite this,
the efficacy of IKur blockers to terminate AF has been shown to be controversial in modelling
[15,24] and experimental [26] studies.
Our results add insight to the on-going discussion: blocking IKur may help to terminate re-
entry, but also increases tissue’s vulnerability to AF initiation. Furthermore, dependent on
baseline AP morphology, blocking IKur may shorten the APD, facilitating sustained re-entry.
Moreover, for paroxysmal AF of which AP parameters could be unaltered [35], blocking IKur
may result in pro-arrhythmic consequences, such as EADs.
Limitations
Limitations of the cellular and 3D models, as well as experimental data acquisition, are dis-
cussed elsewhere [2,13,14]. Here, only limitations associated with the cellular and tissue
modelling of these mutations are discussed.
Due to the limited availability of experimental data, in simulations it was assumed that: the
kinetic effect of the mutants on IKur is homogeneous throughout the atria; the mutants do not
affect the relative response of IKur to beta stimulation; and, the mutant variants of IKur differ
from the WT in the same way for both lone and chronic AF. Moreover, we assumed that these
mutations do not directly induce structural remodelling including fibrosis/atrial enlargement.
Such assumptions require further experimental verifications.
There are multiple confounding factors associated with the complex excitation patterns
observed during AF which were not included in the present study in order to isolate the elec-
trical effects of IKur modifications: (i) the model includes only idealised fibre structure along
the main bundles of the CT/BB and PMs–previous studies have demonstrated a significant
role of fibres in determining complex excitation patterns [15,36,37]; (ii) there is no inclusion
of fibrosis or regional variation in diffusion coefficient–previous studies have demonstrated
the important role of fibrosis and heterogeneous conduction velocity in the breakdown on
excitation wavefronts [29,30]; (iii) atrial dilation and hypertrophy are not included and these
may also promote complex excitation patterns.
Without inclusion of these factors, the complex and multi-wavelet excitation patterns under-
lying AF would not be expected to arise. However, the electrical mechanism underlying
increased vulnerability to sustained arrhythmia is the same in both conditions: namely, shorten-
ing of the effective refractory period and consequently excitation wavelength, permitting faster
and shorter re-entrant waves to be maintained. It is therefore reasonable to assume that promo-
tion of re-entrant activity compared to control is a good indication for the isolated electrical
modulation of vulnerability to complex excitation underlying AF. Moreover, once re-entrant
excitation is initiated (i.e. a mother rotor) the additional factors described above will contribute
to the breakdown of the excitation waves leading to the complex activity associated with AF.
Single cell models used in the present study are not suited for investigating delayed-after-depo-
larisations induced by spontaneous calcium release events, which are being increasingly linked to
AF triggers [38]. Loss-of-function mutations were associated with increased incidence of EADs,
and APD prolongation and EADs are both linked to increased SR loading and probability of
spontaneous release events. These phenomena may play an important role in arrhythmia associ-
ated with loss-of-function mutations but could not be investigated in the present study.
The human SAN model implemented is not rigorously based on detailed electrophysiologi-
cal data from human. However, the model was used in the present study to provide an accurate
excitation driving force associated with sinus rhythm (i.e. rate and AP magnitude) and is
deemed suitable for this purpose due to the faithful reproduction of SAN AP morphology and
conduction. Tissue simulations for the SAN were only performed in 1D because extension to
Pro-arrhythmic effects of KCNA5 gene mutations
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3D requires the inclusion of additional factors determining SAN excitation patterns [39],
beyond the scope of this study, which will have a large influence on the potential generation of
unidirectional conduction patterns.
Conclusion
Genetic variation in KCNA5 promoted multiple mechanisms of arrhythmogenesis for both
gain- and loss-of-function mutations, pertaining to the development of re-entrant excitation
and early-after-depolarisations. Atrial AP morphology was demonstrated to be highly sensitive
to IKur activation kinetics and had a strong impact on tissue dynamics.
Methods
Development of a novel formulation of IKur
A new formulation of IKur was incorporated into the Colman et al. model based on experimen-
tal data from the wild-type (WT) KV1.5 channel [2]. The new formulation of IKur is as follows:
KQ10 ¼ 3:52 ð1Þ
Activation gate:
ainf ¼
1:0
1:0þ expðVþ17:67
  5:75
Þ

1:0
1:0þ expðVþ8:45
  11:51
Þ
ð2Þ
ta ¼
45:67
1:0þ exp Vþ11:23
11:53
  þ 4:27
 !
0:26
1:0þ exp Vþ35:87
  3:88
  þ 0:29
 !
ð3Þ
ta ¼ ta=KQ10 ð4Þ
da
dt
¼
ainf   a
ta
ð5Þ
Inactivation gate:
iinf ¼
0:52
1:0þ expðV   15:11
7:57
Þ
þ 0:46 ð6Þ
ti ¼
2328
1:0þ expðV   9:44
3:58
Þ
þ 1739:14 ð7Þ
ti ¼ ti=KQ10 ð8Þ
di
dt
¼
iinf   i
ti
ð9Þ
IKur current:
IKur ¼ 0:64 4:51þ
1:90
1:0þ exp V   20:52
  8:27
  
 !
a  i  ðV   EKÞ ð10Þ
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The new model mediates an explicit dependence of channel conductivity to the membrane
voltage. The maximum channel conductance was tuned so that the ratio of maximum current
densities of Ito (the transient outward potassium current) and IKur is close to experimental
observations [40]. In accordance with a previous study [21], Q10 correction was carried out to
account for the difference in the temperature at which the experiments were carried out and
physiological conditions. The new formulation of IKur closely reproduces the kinetics of the
current in experimental conditions (Fig 4). Note that the experimental traces of voltage clamp
for IKur show typically two types of activation–fast and slow (Fig 4B)–for different individual
isolated single cells. In the new IKur model, the time constants of activation gate were modelled
by the weighted mean of the fast and slow kinetics observed in the raw data set from the study
[2], representing the homogenising effects of coupled cells in tissue.
To obtain models of the six KCNA5-mutant currents, parameters of channel conductance,
activation and inactivation gates were fitted to individual mutation data from [2], whereas the
time constants were kept the same with the WT model. The resultant activation, inactivation
gates and I-V relationship measured from simulated voltage clamp are presented in Fig 5.
Fig 4. Model representation describing IKur and simulated voltage clamp. A Steady-state activation and inactivation; B Time constants; C
Current trace obtained from a simulated voltage clamp. Inserts: top right–voltage protocol; bottom right–experimental current traces; D I-V
relationship. In the Fig the simulation data were shown using lines, and experimental data represented by points. Experimental data were taken
from [2]; specially, for B the time constants were derived from current traces from [2] by fitting the activation phase of the current trace to a mono-
exponential equation.
https://doi.org/10.1371/journal.pcbi.1005587.g004
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Single cell models
Multiple contemporary models of human atrial electrophysiology (Courtemanche et al. [21];
Grandi et al. [17]; and Colman et al. [13]) were used in the present study. These models exhibit
diverse human atrial action potential properties and profiles.
The novel formulation of IKur was incorporated into the Colman et al. model; the updated
model Colman et al. model was validated against experimental data (S6 Text). In Courte-
manche et al. and Grandi et al. models, effects of mutations on atrial electrophysiology were
simulated by incorporating the relative changes in steady-state gates and conductance relative
to the WT IKur, summarised in Table 1.
S1-S2 stimulation protocol was used to obtain the APD restitutions. For each model, a train
of 100 S1 stimuli of 1000 ms was applied, which was followed by a further stimulus delayed by
S2.
Regional cell models, accounting for variation in APD and AP morphology of difference
regions within the atria, were implemented for the Colman et al. and Courtemanche et al.
Fig 5. Modelling the electrophysiological properties of IKur carried by the mutants. A Steady-state
activation; B Steady-state inactivation; C I-V relationship of IKur elicited by voltage clamp step protocol for the
(i) gain- and (ii) loss-of-function mutations, compared to the WT (black). In the plots points indicate the
experimental data [2] and lines represent simulated results.
https://doi.org/10.1371/journal.pcbi.1005587.g005
Pro-arrhythmic effects of KCNA5 gene mutations
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005587 June 16, 2017 13 / 21
models from previous modelling studies [13,21] (S7 Text). Regional differences between the
electrophysiology of the right atrial bundles of the crista terminalis (CT) and the pectinate
muscles (PM) were also incorporated into the Grandi et al. model [17] based on the same data
(S7 Text).
To study the impact of the mutations on EAD production, the effect of isoprotenerol (ISO,
a β-agonist reproducing sympathetic activity) was incorporated into the Grandi et al. model
according to their original study [17] and into the Courtemanche et al. and Colman et al. mod-
els based on the same parameter modifications.
Models of the KCNA5 mutants were also combined with models of chronic AF-induced elec-
trical remodelling (cAF) (from previous studies[13,17]), affecting the conductance and kinetics
of multiple ion channels, in order to provide insight into the integral action of the arrhythmo-
genic substrate associated with the mutations and that associated with chronic AF (S8 Text).
Tissue modelling
Mathematical model of electrical excitation wave propagation. The wave propagation
of atrial excitation was modelled by the well-known reaction-diffusion equation [13], given by:
@Vm
@t
¼ r  ðDrVmÞ  
Iion
Cm
ð11Þ
where Vm is the membrane potential, D the tensor of diffusion coefficient, Iion the total ionic
transmembrane current in a single cell and the Cm is the membrane capacitance of the cell.
1D strand models. A simplified tissue model is developed in which a string of single cells
are coupled in a 1D strand. Half of the model is the CT and half the PM, representing this
region of the right atrium. The diffusion coefficient is set to give a conduction velocity close to
the experimentally observed values along the fibre direction of 1.3 m/s. The Grandi et al.
model was implemented for the purpose of evaluating the behaviour of EADs in tissue.
We also constructed 1D strand models of the conduction pathways from the SAN to the
surrounding atria. The CT/PM/RAA cell models are from the Grandi et al., as described
previously (S7 Text). The SAN cell model was derived from the Colman et al. model and is
an identical implementation to previous publications [14,41], based on mRNA data [42,43].
The morphology of simulated AP in the SAN model is comparable to experimental traces
(Figure A in S9 Text).
3D anatomical human atrial model. Our previously developed 3D virtual human atria
[13,14,44] was applied to assess the functional impact of the mutations on electrical wave
behaviour in the organ. Details of the model have been previously published [13,14] and are
Table 1. Changes in parameters of steady-state variables and maximum conductance of IKur carried by the KCNA5 mutants relative to WT.
D332H E48G A305T Y155C D469E P488S
Activation V1/2 -3.264 -3.024 -4.068 -0.893 0 0
K × 0.809 × 0.956 × 1.101 × 0.757 × 1 × 0.834
Inactivation V1/2 + 9.615 + 4.028 + 6.032 + 5.013 + 4.545 - 1.415
K × 0.801 × 0.940 × 0.748 × 0.782 × 0.842 × 0.688
Minimum Availability
(MA)
+ 0.074 + 0.039 + 0.071 + 0.035 - 0.093 - 0.110
Maximum Conductance × 1.799 × 1.323 × 1.445 × 0.475 × 0.546 × 0.038
Steady-state activation and inactivation were described using Bolzmann equation. For activation: I/Imax = 1/{1 + exp[(V − V1/2)/k]}, inactivation I/Imax = (1 −
MA)/{1 + exp[(V − V1/2)/k]} + MA. Parameters were fitted to the experimental data digitalised from [2].
https://doi.org/10.1371/journal.pcbi.1005587.t001
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introduced in S10 Text. Briefly, the anatomical atrial model is derived from the visible human
dataset [44] and segmented into the major differentiated anatomical regions [13,44]. For all
simulations, the model was preconditioned by implementing the initial conditions for all state
variables as the stable-state values from a 1D tissue strand paced at 1Hz for 100 beats. Sinus
rhythm was simulated by pacing the atria from the sinoatrial node region. APD was measured
to an accuracy of 1 ms at each node on the final of 10 beats at 1Hz, using the time at which
voltage reaches above -40 mV as the upstroke time.
3D Modelling of atrial vulnerability to unidirectional conduction block. Atrial vulnera-
bility to unidirectional conduction block was quantified by an S1S2 pacing protocol applied to
the heterogeneous junction [13,14,45] of the CT with the PM within a 3D atrial wedge (Fig
Fig 6. An example of simulated excitation wave break following S1-S2 stimuli at the CT/PM junction. A
Volume rendering of the 3D human atrial wedge used in the simulations; S1-S2 were applied to the junction of
CT/PM (indicated with white square wave in the top right panel); the labels are: SVC/IVC–superior/inferior
vena cava, RA–right atrium, PM–pectinate muscle, CT–crista terminalis; B Simulated wave break arising from
the S2 stimulus shown in A; the arrows indicate the direction of wave propagation.
https://doi.org/10.1371/journal.pcbi.1005587.g006
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6A). A train of 7 S1 stimuli at 500ms was applied to a spherical tissue region of 3.3 mm in
radius, which was followed by an S2 at variant intervals applied to the same site. This protocol
has been used in previous studies [13]. The temporal vulnerability window was defined as the
Fig 7. Illustration of the phase distribution method to initiate re-entrant waves in the 3D human atrial model. A
The distributed phase map used on the anatomical model, with numbered indications of the stage of the AP which is
mapped onto each location; RAA–right atrial appendage, PV–pulmonary vein, LA–left atrium; B Demonstration of the
development of a spiral wave in the tissue with mapped initial conditions; the time of screenshot is indicated in the top of
each panel.
https://doi.org/10.1371/journal.pcbi.1005587.g007
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temporal range of S2 giving rise to wave break in either direction but not both. An example of
simulated wave break is presented in Fig 6B.
Initiation of re-entry in the human atria. To study the effect of the mutation induced
alterations to parameters of AP on re-entrant wave dynamics, a phase-distribution method
was implemented in order to attain re-entrant excitation independent of initiation methods
[46,47]. Whereas this initiation mechanism is artificial, it allows for the investigation of the
long term dynamics of excitation.
The phase distribution method involves mapping the state variables from the single cell
model onto the anatomical model to create an asymmetric conduction pattern: (1) export the
state variables from the resultant AP of the final stimulus applied to a 1D strand of homoge-
neous tissue, at discrete intervals throughout an entire AP cycle (Fig 7A); (2) use these values
as the initial conditions in the 3D model, spatially distributed throughout the anatomy to cre-
ate an asymmetric propagation wave which will develop into a spiral/scroll (Fig 7B).
Note that in simulations the diffusion coefficient (D, diffusion tensor in the monodomain
equation) in the model, mimicking the intercellular electrical coupling, was varied between
100% (control, lone AF) and 40% (severe remodelling) to simulate possible remodelling in the
connexin and atrial structures (e.g. 30% increase in the atrial volume) associated with AF [48–
50], which resulted in up to 40% reduction in the conduction velocity as seen in previous stud-
ies [49,51,52]. A reduction in D promotes sustained re-entry, and thus the extent of the reduc-
tion required to sustain re-entry is an indicator of vulnerability. The dominant frequencies
(DF) of sustained re-entrant excitation were then computed through Fourier analysis of the
electrical activity in multiple single cells in different regions throughout the tissue [13]. DF
computation was used as a measure of the ability of the atria to sustain rapid excitation;
detailed spatial DF maps to demonstrate regional variation in excitation frequency and identify
driving rotors were not computed due to (i) the direct control over the initiation of re-entry
and (ii) the single mother rotor excitation observed (see Results).
For each mutation and WT with Colman et al. and Courtemanche et al. models, the first
5000 ms following initiation of re-entry was simulated and recorded for analysis.
A description of the numerical methods used in this study is given in S11 Text.
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